Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hamidi, A. Szema, S. Said (Stony Brook, NY, Northport, NY, United States Of America). A single pathogenetic mechanism for vascular remodeling and inflammation in PAH. Eur Respir J 2008; 32: Suppl. 52, 275

Member's Comments

No comment yet.

Related content which might interest you: The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Neurokinins contribute to vascular remodelling in a model of chronic pulmonary allergic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 760s Year: 2006 Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 CFTR in the regulation of pulmonary vascular tone and remodeling Source: Eur Respir J, 58 (6) 2101861; 10.1183/13993003.01861-2021 Year: 2021 The role of small-airway inflammation and remodeling in asthma Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance Year: 2013 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 The role of oxidative damage in pathogenesis of experimental pulmonary emphysema Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD Year: 2007 The role of monocyte inflammation and oxidant stress in the etiopathogenesis of cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2015; 46: 431-443 Year: 2015 Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Involvement of FHL1 in vascular remodelling Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 Mechanisms underlying pulmonary vascular changes in COPD patients Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019